Concepts on the pathogenesis of juvenile idiopathic arthritis;Vorstellungen zur pathogenese der juvenilen idiopathischen arthritis

Zeitschrift fur Rheumatologie

Volumn 67, Issue 2, 2008, Pages 111-120

  Niehues, T ^a   Feyen, O ^b   Telieps, T ^b  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Acquired immune system; Cytokines; Immune reaction; Innate immune system; Molecular genetic methods

Indexed keywords

CYTOKINE;

ADAPTIVE IMMUNITY; ARTICLE; GENOMICS; INNATE IMMUNITY; JUVENILE RHEUMATOID ARTHRITIS; PATHOGENESIS; PROTEOMICS; REGULATORY T LYMPHOCYTE; STRESS; T LYMPHOCYTE; VIRUS INFECTION;

ADOLESCENT; ARTHRITIS, JUVENILE RHEUMATOID; CHILD; CYTOKINES; HUMANS; IMMUNITY, NATURAL; MODELS, IMMUNOLOGICAL;

EID: 41749112202     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-008-0276-7     Document Type: Article

References (71)

1. Aggarwal A, Agarwal S, Misra R (2007) Chemokine and chemokine receptor analysis reveals elevated interferon-inducible protein-10 (IP)-10/CXCL10 levels and increased number of CCR5+ and CXCR3+ CD4 T cells in synovial fluid of patients with enthesitis-related arthritis (ERA). Clin Exp Immunol 148: 515-519
2. Agostini L, Martinon F, Burns K et al. (2004) NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20: 319-325
3. Allantaz F, Chaussabel D, Stichweh D et al. (2007) Blood leukocyte microarrys to diganose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade. J Exp Med 21: 31-44
4. Andrews NR, Chaney JM, Mullins LL et al. (2007) Brief report: illness intrusiveness and adjustment among native American and Caucasian parents of children with juvenile rheumatic diseases. J Pediatr Psychol 32: 1259-1263
5. Aupperle KR, Bennett BL, Boyle DL et al. (1999) NFkappa B regulation by I kappa B kinase in primary fibroblast-like synoviocytes. J Immunol 163: 427-433
6. Chikanza IC, Kuis W, Heijnen CJ (2000) The influence of the hormonal system on pediatric rheumatic diseases. Rheum Dis Clin North Am 26: 911-925
7. De Benedetti F, Meazza C, Vivarelli M et al. (2003) Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 48: 1398-1407
8. Jager W de, Hoppenreijs EP, Wulffraat NM et al. (2007) Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study. Ann Rheum Dis 66: 589-598
9. Kleer IM de, Kamphuis SM, Rijkers GT et al. (2003) The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. Arthritis Rheum 48: 2001-2010
10. Kleer IM de, Wedderburn LR, Taams LS et al. (2004) CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 172: 6435-6443
11. Delpech M, Grateau G (2001) Genetically determined recurrent fevers. Curr Opin Immunol 13: 539-542
12. Donn RP, Farhan A, Stevans A et al. (2002) Neuroendocrine gene polymorphisms and susceptibility to juvenile idiopathic arthritis. Rheumatology (Oxford) 41: 930-936
13. Drenth JP, Meer JW van der (2006) The inflammasome-a linebacker of innate defense. N Engl J Med 355: 730-732
14. Faber C, Morbach H, Singh SK, Girschick HJ (2006) Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis. Ann Rheum Dis 65: 1351-1356
15. Fall N, Barnes M, Thornton S et al. (2007) Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. Arthritis Rheum 56: 3793-3804
16. Fishman D, Faulds G, Jeffery R et al. (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102: 1369-1376
17. Foell D, Wittkowski H, Roth J (2007) Mechanisms of disease: 'DAMP' view of inflammatory arthritis. Nat Clin Pract Rheumatol 3: 382-390
18. Frenkel LM, Nielsen K, Garakian A et al. (1996) A search for persistent rubella virus infection in persons with chronic symptoms after rubella and rubella immunization and in patients with juvenile rheumatoid arthritis. Clin Infect Dis 22: 287-294
19. Gattorno M, Prigione I, Morandi F et al. (2005) Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis. Arthritis Res Ther 7: R256-R267
20. Gibson DS, Bielock S, Brockbank S et al. (2006) Proteomic analysis of recurrent joint inflammatio in juvenile idiopathic arthritis. J Proteome Res 5: 1988-1995
21. Goldbach-Mansky R, Dailey NJ, Canna SW et al. (2006) Neonatal-onset multisystem inflammatory disease responsive to interleukin-1beta inhibition. N Engl J Med 355: 581-592
22. Gonzalez B, Larranaga C, Leon O et al. (2007) Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis. J Rheumatol 34: 1336-1340
23. Goodyear M (2006) Learning from the TGN1412 trial. BMJ 332: 677-678
24. Graham B, Gibson SB (2005) The two faces of NFkappaB in cell survival responses. Cell Cycle 4: 1342-1345
25. Gregersen PK (2007) Modern genetics, ancient defenses, and potential therapies. N Engl J Med 356: 1263-1266
26. regorio A, Gambini C, Gerloni V et al. (2007) Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. Rheumatology (Oxford) 46: 308-313
27. Grom AA, Hirsch R (2000) T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 12: 420-424
28. Handel ML, Girgis L (2001) Transcription factors. Best Pract Res Clin Rheumatol 15: 657-675
29. Hasko G, Cronstein BN (2004) Adenosine: an endogenous regulator of innate immunity. Trends Immunol 25: 33-39
30. Hinks A, Barton A, John S et al. (2005) Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. Arthritis Rheum 52: 1694-1699
31. Jarvis JN, Jiang K, Petty HR, Centola M (2007) Neutrophils: the forgotten cell in JIA disease pathogenesis. Pediatr Rheumatol Online J 5: 13
32. Kamphuis S, Hrafnkelsdottir K, Klein MR et al. (2006) Novel self-epitopes derived from aggrecan, fibrillin, and matrix metalloproteinase-3 drive distinct autoreactive T-cell responses in juvenile idiopathic arthritis and in health. Arthritis Res Ther 8: R178
33. Kamphuis S, Kuis W, Jager W de et al. (2005) Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366: 50-56
34. Knipp S, Feyen O, Ndagijimana J, Niehues T (2003) Ex vivo apoptosis, CD95 and CD28 expression in T cells of children with juvenile idiopathic arthritis. Rheumatol Int 23: 112-115
35. Kremer JM, Dougados M, Emery P et al. (2005) Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial. Arthritis Rheum 52: 2263-2271
36. Kremer JM, Westhovens R, Leon M et al. (2003) Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N Engl J Med 349: 1907-1915
37. Lehmann HW, Knoll A, Kuster RM, Modrow S (2003) Frequent infection with a viral pathogen, parvovirus B19, in rheumatic diseases of childhood. Arthritis Rheum 48: 1631-1638
38. Lequerre T, Quartier P, Rosellini D et al. (2007) Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still's disease. Preliminary experience in France. Ann Rheum Dis [E-pub ahead of print, Oct 18]
39. Lindner E, Nordang GB, Melum E et al. (2007) Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis. BMC Med Genet 8: 33
40. Lundy SK, Sarkar S, Tesmer LA, Fox DA (2007) Cells of the synovium in rheumatoid arthritis. T lymphocytes. Arthritis Res Ther 9: 202
41. Maccioni M, Zeder-Lutz G, Huang H et al. (2002) Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 195: 1071-1077
42. Mariathasan S, Monack DM (2007) Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 7: 31-40
43. Martini G, Zulian F, Calabrese F et al. (2005) CXCR3/CXCL10 expression in the synovium of children with juvenile idiopathic arthritis. Arthritis Res Ther 7: R241-R249
44. Massa M, Mazzoli F, Pignatti P et al. (2002) Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. Arthritis Rheum 46: 2721-2729
45. Mayor S (2006) Severe adverse reactions prompt call for trial design changes. BMJ 332: 683
46. Mitchell JA, Paul-Clark MJ, Clarke GW et al. (2007) Critical role of toll-like receptors and nucleotide oligomerisation domain in the regulation of health and disease. J Endocrinol 193: 323-330
47. Miyamae T, Malehorn DE, Lemster B et al. (2005) Serum protein profile in systemic-onset juvenile idiopathic arthritis differentiates response versus nonresponse to therapy. Arthritis Res Ther 7: R746-R755
48. Niehues T, Reichenbach J, Neubert J et al. (2004) Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia. J Allergy Clin Immunol 114: 1456-1462
49. Ogilvie EM, Khan A, Hubank M et al. (2007) Specific gene expression profiles in systemic juvenile idiopathic arthritis. Arthritis Rheum 56: 1954-1965
50. Okamoto T (2006) NF-kappaB and rheumatic diseases. Endocr Metab Immune Disord Drug Targets 6: 359-372
51. Pap T (2007) [Regulation of apoptosis in aggressive fibroblasts]. Z Rheumatol 66: 239-240, 242
52. Petty RE, Southwood TR, Manners P et al. (2004) International league of associations for rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 31: 390-392
53. Pharoah DS, Varsani H, Tatham RW et al. (2006) Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells. Arthritis Res Ther 8: R50
54. Prahalad S, Bohnsack JF, Jorde LB et al. (2006) Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis. Genes Immun 7: 468-475
55. Puga Yung GL, Le TD, Roord S et al. (2003) Heat shock proteins (HSP) for immunotherapy of rheumatoid arthritis (RA). Inflamm Res 52: 443-451
56. Ravelli A, Martini A (2007) Juvenile idiopathic arthritis. Lancet 369: 767-778
57. Rieck M, Arechiga A, Onengut-Gumuscu S et al. (2007) Genetic variation in PTPN22 corresponds to altered function of T and B lymphocytes. J Immunol 179: 4704-4710
58. Roupe van der Voort C, Heijnen CJ, Wulffraat N et al. (2000) Stress induces increases in IL-6 production by leucocytes of patients with the chronic inflammatory disease juvenile rheumatoid arthritis: a putative role for alpha(1)- adrenergic receptors. J Neuroimmunol 110: 223-229
59. Ruprecht CR, Gattorno M, Ferlito F et al. (2005) Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia. J Exp Med 201: 1793-1803
60. Sioud M, Kjeldsen-Kragh J, Suleyman S et al. (1992) Limited heterogeneity of T cell receptor variable region gene usage in juvenile rheumatoid arthritis synovial T cells. Eur J Immunol 22: 2413-2418
61. Sioud M, Mellbye O, Forre O (1998) Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. Clin Exp Rheumatol 16: 125-134
62. Smolewska E, Brozik H, Smolewski P et al. (2004) Regulation of peripheral blood and synovial fluid lymphocyte apoptosis in juvenile idiopathic arthritis. Scand J Rheumatol 33: 7-12
63. Thomson W, Barrett JH, Donn R et al. (2002) Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. Rheumatology (Oxford) 41: 1183-1189
64. Tsai YT, Chiang BL, Kao YF, Hsieh KH (1995) Detection of Epstein-Barr virus and cytomegalovirus genome in white blood cells from patients with juvenile rheumatoid arthritis and childhood systemic lupus erythematosus. Int Arch Allergy Immunol 106: 235-240
65. Vabulas RM, Ahmad-Nejad P, da Costa C et al. (2001) Endocytosed HSP60 s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J Biol Chem 276: 31332-31339
66. Vogl T, Tenbrock K, Ludwig S et al. (2007) Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med 13: 1042-1049
67. Wan B, Nie H, Liu A et al. (2006) Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis. J Immunol 177: 8844-8850
68. Wedderburn LR, Robinson N, Patel A et al. (2000) Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. Arthritis Rheum 43: 765-774
69. Weissbrich B, Suss-Frohlich Y, Girschick HJ (2007) Seroprevalence of parvovirus B19 IgG in children affected by juvenile idiopathic arthritis. Arthritis Res Ther 9: R82
70. Woo P, Wilkinson N, Prieur AM et al. (2005) Open label phase II trial of single, ascending doses of MRA in Caucasian children with severe systemic juvenile idiopathic arthritis: proof of principle of the efficacy of IL-6 receptor blockade in this type of arthritis and demonstration of prolonged clinical improvement. Arthritis Res Ther 7: R1281-R1288
71. Yokota S, Miyamae T, Imagawa T et al. (2005) Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 52: 818-825